From Blood Plasma to Drugs
Blood saves life - in many ways.
The manufacture of pharmaceutical products from blood plasma by plasma fractionation requires process conditions that are particularly kind to the product. It is done to the greatest possible extent under sterile conditions and requires materials and processing of the highest quality. In addition, a large number of national and international standards and statutory provisions have to be complied with. Manufacturers therefore expect great precision in the manufacture and assembly of their process plants. Every detail of the design must comply with high-quality standard in order to avoid production errors. If these conditions are fulfilled by high-performance processing equipment, reliable production is guaranteed.
All Production Steps from one Source
As a competent manufacturer of complete plants for the pharmaceutical industry, GEA Diessel offers you full service for every requirement and to meet every specification. From the planning, development and installation of your new process plant all the way to qualification and maintenance - our experienced engineers will collaborate with your project team to develop innovative and efficient process technologies for your own very individual blood plasma processing applications.
Performance and Quality
Whatever it is you need your process plant for - the fractionation and manufacture of products from immuno globulins, human albu-mins, Factor VIII, Factor IX or whatever - the great diversity of our plant concepts will provide for any task to be performed and take account of any requirements or conditions.
By providing state-of-the-art components and valve technique as well as most advanced production concepts for vessels and skid GEA Diessel offers you an economic and gentle manufacturing of your products.
For detailed information please refer to our brochure "Process plant for pharmaceutical and biotechnology industries".